FLGT
FLGT
NASDAQ · Health Care

Fulgent Genetics Inc

$15.96
+0.85 (+5.63%)
As of May 9, 9:40 PM ET ·
Financial Highlights (FY 2026)
Revenue
313.06M
Net Income
-58,710,619
Gross Margin
40.6%
Profit Margin
-18.8%
Rev Growth
-19.5%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 40.6% 40.6% 39.4% 39.4%
Operating Margin -31.3% -28.2% 19.5% 19.5%
Profit Margin -18.8% -17.8% 13.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 313.06M 388.99M 242.23M 275.80M
Gross Profit 126.98M 157.77M 95.53M 108.77M
Operating Income -98,018,338 -109,612,952 47.17M 53.86M
Net Income -58,710,619 -65,655,513 32.57M 36.27M
Gross Margin 40.6% 40.6% 39.4% 39.4%
Operating Margin -31.3% -28.2% 19.5% 19.5%
Profit Margin -18.8% -17.8% 13.5% 13.2%
Rev Growth -19.5% -19.5% -1.5% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 565.2K 565.2K 257.54M 237.86M
Total Equity 226.07M 226.07M 521.51M 552.15M
D/E Ratio 0.00 0.00 0.49 0.43
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -90,072,517 -106,323,174 59.74M 74.06M
Free Cash Flow 22.63M 30.51M